Research
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
BMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j1550 (Published 26 April 2017) Cite this as: BMJ 2017;357:j1550
Data supplement
Web Extra
- Data Supplement - Appendix 1: Searches
- Data Supplement - Appendix 2: Supplementary tables A and B
- Data Supplement - Appendix 3: Quality score
Web Extra
- Data Supplement - Appendix 1: Searches
- Data Supplement - Appendix 2: Supplementary tables A and B
- Data Supplement - Appendix 3: Quality score
Related articles
- Editorial Published: 26 April 2017; BMJ 357 doi:10.1136/bmj.j1947
See more
- Release of immigration detainees: RECONNECTed yet not protected from harm of detentionBMJ February 25, 2020, 368 m712; DOI: https://doi.org/10.1136/bmj.m712
- Acknowledge, in the curriculum, those who suffered for the advancement of medical scienceBMJ February 25, 2020, 368 m714; DOI: https://doi.org/10.1136/bmj.m714
- Dementia: US recommends against screening over 65s because of insufficient evidenceBMJ February 25, 2020, 368 m750; DOI: https://doi.org/10.1136/bmj.m750
- Helen Salisbury: PrestidigitationBMJ February 25, 2020, 368 m648; DOI: https://doi.org/10.1136/bmj.m648
- My hopes for a thriving primary care have been dashedBMJ February 25, 2020, 368 m623; DOI: https://doi.org/10.1136/bmj.m623
Cited by...
- Opioid agonist therapy during residential treatment of opioid use disorder: Cohort study on access and outcomes
- Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline
- Canadas hidden opioid crisis: the health care systems inability to manage high-dose opioid patients: Fallout from the 2017 Canadian opioid guidelines
- La crise cachee des opioides au Canada : lincapacite du systeme de sante de gerer les patients prenant de fortes doses dopioides: Repercussions des recommandations canadiennes de 2017 sur les opioides
- Supporting Physicians and Practice Teams in Efforts to Address the Opioid Epidemic
- Quality of primary care among individuals receiving treatment for opioid use disorder
- Patient-centred care in opioid agonist treatment could improve outcomes
- Slow release oral morphine versus methadone for the treatment of opioid use disorder
- Youth and the Opioid Epidemic
- Are New Residency Graduates Prepared to Treat Opioid Use Disorder?
- Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
- Improving wait time from referral to opiate replacement therapy in a drug recovery service
- The 2017 Canadian opioid guideline: already time for an overhaul
- Management of opioid use disorders: a national clinical practice guideline
- Narrowing the treatment gap in managing opioid use disorder
- Suboxone: Rationale, Science, Misconceptions
- Availability of naloxone in Canadian pharmacies:a population-based survey
- Opioid agonist therapy
- Opioid substitution treatment is linked to reduced risk of death in opioid use disorder